Fig. 2From: Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension studyPercentage of patients with gout flare requiring treatment in intention-to-treat population receiving lesinurad + febuxostat up to 24 months. CONT Continuation of lesinurad treatment, CROSS Crossover from core study placebo to lesinurad treatmentBack to article page